StockNews.com Begins Coverage on DURECT (NASDAQ:DRRX)

Equities researchers at StockNews.com began coverage on shares of DURECT (NASDAQ:DRRX – Get Rating) in a report released on Thursday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. DRRX has been the subject of several other reports. Jonestrading started coverage on shares of DURECT in a research note on Tuesday, March […]

Related Keywords

United States ,America ,Jamese Brown , ,Epigenetic Regulator Program ,Financial Group ,Cantor Fitzgerald ,Tower Research Capital ,Atria Wealth Solutions Inc ,Prelude Capital Management ,America Corp ,Get Rating ,Wealth Solutions ,Research Capital ,Capital Management ,Merit Financial Group ,Epigenetic Regulator ,Felix Theeuwes ,Durect ,Nasdaq Drrx ,Drrx ,Medical ,Initiated Coverage ,Stocknews Com ,